Craig Taylor

Craig Taylor has a diverse work experience that spans over several industries. Craig is currently serving as the Sr Director of Strategic Operations at Tenpoint Therapeutics Ltd, a biotechnology company focused on developing therapies for ocular diseases. Prior to this, they worked as the Director of Takeda ADT Operations at Takeda, a pharmaceutical company. Craig also held the position of Head of Business Operations at Adaptate, an immunotherapy company. Additionally, Craig has experience as the Director of Business Development at Virion Biotherapeutics and the VP (Head) of Business Development at Congenica. Craig worked as a Consultant at GfK Market Access, where they provided strategic initiatives for healthcare clients. Craig also has experience as an Independent Consultant and a Business Development Intern at F-star Biotechnology Ltd. Craig started their career at NanoString Technologies and Starbucks Coffee Company, where they held supply chain-related roles.

Craig Taylor holds an MBA degree with a concentration in Finance from the University of Cambridge, which they obtained from 2011 to 2012. Craig also obtained a Bachelor of Science degree in Manufacturing and Supply Chain Management from Western Washington University from 2004 to 2006. Prior to that, they earned an Associate of Arts degree in General Studies with a Business Emphasis from Centralia College from 2002 to 2004. In addition to their formal education, Craig Taylor obtained a certification in Adverse Event Reporting in Market Research from the British Healthcare Business Intelligence Association in September 2013.